This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hickman, E. S.
Right arrow Articles by Vousden, K. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hickman, E. S.
Right arrow Articles by Vousden, K. H.

 Previous Article  |  Next Article 

J. Virol., May 1997, 3710-3718, Vol 71, No. 5
Copyright © 1997, American Society for Microbiology

Perturbation of the p53 response by human papillomavirus type 16 E7

ES Hickman, S Bates and KH Vousden
Frederick Cancer Research and Development Center, National Cancer Institute, Maryland 21702, USA.

The p53 tumor suppressor protein can induce both cell cycle arrest and apoptosis in DNA-damaged cells. In human carcinoma cell lines expressing wild-type p53, expression of E7 allowed the continuation of full cell cycle progression following DNA damage, indicating that E7 can overcome both G1 and G2 blocks imposed by p53. E7 does not interfere with the initial steps of the p53 response, however, and E7 expressing cells showed enhanced expression of p21(waf1/cip1) and reductions in cyclin E- and A-associated kinase activities following DNA damage. One function of cyclin-dependent kinases is to phosphorylate pRB and activate E2F, thus allowing entry into DNA synthesis. Although E7 may substitute for this activity during cell division by directly targeting pRB, continued cell cycle progression in E7-expressing cells was associated with phosphorylation of pRB, suggesting that E7 permits the retention of some cyclin-dependent kinase activity. One source of this activity may be the E7-associated kinase, which was not inhibited following DNA damage. Despite allowing cell cycle progression, E7 was unable to protect cells from p53-induced apoptosis, and the elevated apoptotic response seen in these cells correlated with the reduction of cyclin A-associated kinase activity. It is possible that inefficient cyclin A-dependent inactivation of E2F at the end of DNA synthesis contributes to the enhanced apoptosis displayed by E7-expressing cells.


This article has been cited by other articles:

  • McMurray, H. R., McCance, D. J. (2004). Degradation of p53, Not Telomerase Activation, by E6 Is Required for Bypass of Crisis and Immortalization by Human Papillomavirus Type 16 E6/E7. J. Virol. 78: 5698-5706 [Abstract] [Full Text]  
  • Nair, P., Somasundaram, K., Krishna, S. (2003). Activated Notch1 Inhibits p53-Induced Apoptosis and Sustains Transformation by Human Papillomavirus Type 16 E6 and E7 Oncogenes through a PI3K-PKB/Akt-Dependent Pathway. J. Virol. 77: 7106-7112 [Abstract] [Full Text]  
  • Westbrook, T. F., Nguyen, D. X., Thrash, B. R., McCance, D. J. (2002). E7 Abolishes Raf-Induced Arrest via Mislocalization of p21Cip1. Mol. Cell. Biol. 22: 7041-7052 [Abstract] [Full Text]  
  • Chattopadhyay, D., Ghosh, M. K., Mal, A., Harter, M. L. (2001). Inactivation of p21 by E1A Leads to the Induction of Apoptosis in DNA-Damaged Cells. J. Virol. 75: 9844-9856 [Abstract] [Full Text]  
  • Flatt, P. M., Tang, L. J., Scatena, C. D., Szak, S. T., Pietenpol, J. A. (2000). p53 Regulation of G2 Checkpoint Is Retinoblastoma Protein Dependent. Mol. Cell. Biol. 20: 4210-4223 [Abstract] [Full Text]  
  • Liu, J.-L., Ye, Y., Qian, Z., Qian, Y., Templeton, D. J., Lee, L. F., Kung, H.-J. (1999). Functional Interactions between Herpesvirus Oncoprotein MEQ and Cell Cycle Regulator CDK2. J. Virol. 73: 4208-4219 [Abstract] [Full Text]  
  • Bond, J. A., Haughton, M. F., Rowson, J. M., Smith, P. J., Gire, V., Wynford-Thomas, D., Wyllie, F. S. (1999). Control of Replicative Life Span in Human Cells: Barriers to Clonal Expansion Intermediate Between M1 Senescence and M2 Crisis. Mol. Cell. Biol. 19: 3103-3114 [Abstract] [Full Text]  
  • Mulloy, J. C., Kislyakova, T., Cereseto, A., Casareto, L., LoMonico, A., Fullen, J., Lorenzi, M. V., Cara, A., Nicot, C., Giam, C.-Z., Franchini, G. (1998). Human T-Cell Lymphotropic/Leukemia Virus Type 1 Tax Abrogates p53-Induced Cell Cycle Arrest and Apoptosis through Its CREB/ATF Functional Domain. J. Virol. 72: 8852-8860 [Abstract] [Full Text]  
  • Song, S., Gulliver, G. A., Lambert, P. F. (1998). Human papillomavirus type 16 E6 and E7 oncogenes abrogate radiation-induced DNA damage responses in vivo through p53-dependent and p53-independent pathways. Proc. Natl. Acad. Sci. USA 95: 2290-2295 [Abstract] [Full Text]  
  • Schulze, A., Mannhardt, B., Zerfass-Thome, K., Zwerschke, W., Jansen-Durr, P. (1998). Anchorage-Independent Transcription of the Cyclin A Gene Induced by the E7 Oncoprotein of Human Papillomavirus Type 16. J. Virol. 72: 2323-2334 [Abstract] [Full Text]  
  • Thomas, J. T., Laimins, L. A. (1998). Human Papillomavirus Oncoproteins E6 and E7 Independently Abrogate the Mitotic Spindle Checkpoint. J. Virol. 72: 1131-1137 [Abstract] [Full Text]  
  • Jones, D. L., Alani, R. M., Munger, K. (1997). The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2. Genes Dev. 11: 2101-2111 [Abstract] [Full Text]  
  • Liu, Y., Hong, Y., Androphy, E. J., Chen, J. J. (2000). Rb-independent Induction of Apoptosis by Bovine Papillomavirus Type 1 E7 in Response to Tumor Necrosis Factor alpha. J. Biol. Chem. 275: 30894-30900 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»